NuWays Initiates Gallmetzer HealthCare With BUY
Analysis based on 6 articles · First reported Sep 21, 2026 · Last updated Sep 21, 2026
The initiation is a single-broker research note on a small-cap Italian dental healthcare company, so its broader market impact is limited and largely confined to Gallmetzer HealthCare shares and sector peers. A BUY rating with a EUR 4.40 target may support positive sentiment and incremental trading interest in the stock, but it does not materially move wider equity, rate, or commodity markets.
NuWays AG initiated coverage of Gallmetzer HealthCare SpA with a BUY recommendation and a 12-month target price of EUR 4.40 per share, based on a DCF valuation. Analyst Sarah Hellemann described Gallmetzer HealthCare as a vertically integrated dental healthcare platform combining a resilient, cash-generative distribution business with higher-growth, higher-margin operations in dental anesthetics and sustainability-focused premium oral care. The report highlights Gerho, Italy's second-largest dental distributor with roughly a 40-year track record and about 55,850 customers, as the resilient foundation and route to market. Intermedical Pharma is positioned to enter the local anesthetics market, holding AIFA-approved marketing authorizations for a generic dental local anesthetic, which NuWays expects to become a growth and margin engine. The premium oral care brand PROMIS, in which Gallmetzer HealthCare holds a 70 percent stake, adds further growth potential through organic certification and international expansion, including a US market entry in April 2025 via PROMIS USA and a new PROMIS Kids line in FY26. NuWays forecasts organic revenue growth of 7.7 percent CAGR through FY30e and 5.2 percentage points of EBITDA margin expansion to 6.9 percent, with acquisitions in the fragmented European dental distribution market and recognition of Intermedical Pharma dossiers in additional European countries as key catalysts.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard